Literature DB >> 27381263

A Randomized Study of SheathLess vs Standard Guiding Catheters for Transradial Percutaneous Coronary Interventions.

Stephane Noble1, Elena Tessitore2, Baris Gencer2, Marc Righini3, Helia Robert-Ebadi3, Marco Roffi2, Robert F Bonvini4.   

Abstract

BACKGROUND: The small diameter of radial arteries remains a major limitation of the transradial approach for percutaneous coronary intervention (PCI). Sheathless guiding catheters (GCs) might offer an advantage over standard GCs.
METHODS: Between 2011 and 2013, we randomized 233 transradial PCIs performed in men with ostial or bifurcation lesions and in all women between standard GC (Medtronic Launcher; Minneapolis, MN) and the SheathLess Eaucath GC (Asahi Intecc, Aichi, Japan).
RESULTS: Successful PCI using the transradial approach was not different between the groups (P = 0.74), however the rate of successful transradial PCI with the designated GC (ie, without crossover to the opposing GC) was superior in the SheathLess group compared with the standard GC group (96.5% vs 89.9%; P = 0.047). Safety end point (ie, absence of PCI complication, radial artery occlusion, perforation, pseudoaneurysm, and Early Discharge after Transradial Stenting of Coronary Arteries [EASY] hematoma grade ≥ 2) did not differ between the groups (60.5% in both groups). Mean PCI duration (45.1 minutes vs 45.9 minutes), fluoroscopy (20.1 minutes and 19.9 minutes), and cannulation times (3.6 minutes vs 3.7 minutes), contrast media volume (196 mL vs 187 mL) and conversion to transfemoral approach (1.8% vs 0.8%) were not different between the groups. Patients' subjective assessment revealed less arm pain during navigation of the SheathLess GC (1.9 ± 1.9 vs 4.8 ± 3.6; P < 0.001). Operators graded arm crossability as easier with the SheathLess GC (8.7 ± 1.5 vs 5.1 ± 3.5; P < 0.001).
CONCLUSIONS: In selected coronary lesions requiring large-bore catheters in men and in all lesions in women, the SheathLess GC was superior to the standard GC for successful transradial PCI with the designated GC. The SheathLess GC was also associated with easier arm navigation and less patient discomfort. Copyright Â
© 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27381263     DOI: 10.1016/j.cjca.2016.03.016

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  5 in total

Review 1.  Radial Artery and Ulnar Artery Occlusions Following Coronary Procedures and the Impact of Anticoagulation: ARTEMIS (Radial and Ulnar ARTEry Occlusion Meta-AnalysIS) Systematic Review and Meta-Analysis.

Authors:  George Hahalis; Konstantinos Aznaouridis; Gregory Tsigkas; Periklis Davlouros; Ioanna Xanthopoulou; Nikolaos Koutsogiannis; Ioanna Koniari; Marianna Leopoulou; Olivier Costerousse; Dimitris Tousoulis; Olivier F Bertrand
Journal:  J Am Heart Assoc       Date:  2017-08-23       Impact factor: 5.501

2.  Postprocedural radial artery occlusion rate using a sheathless guiding catheter for left ventricular endomyocardial biopsy performed by transradial approach.

Authors:  Behrouz Kherad; Clemens Köhncke; Frank Spillmann; Heiner Post; Michel Noutsias; Burkert Pieske; Florian Krackhardt; Carsten Tschöpe
Journal:  BMC Cardiovasc Disord       Date:  2016-12-08       Impact factor: 2.298

3.  Novel treatment of severe radial artery spasm using "homemade sheathless technique": A case report.

Authors:  Zaiyong Zhang; Qiang Xie
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

4.  Sheathless guiding catheter from a femoral approach for complex percutaneous coronary interventions -An unusual solution for an often-encountered problem.

Authors:  Zeev Israeli; Irina Nordkin; Alexander Goldberg; Majdi Halabi
Journal:  Clin Case Rep       Date:  2019-11-22

5.  Slender Sheath/Guiding Catheter Combination vs. Sheathless Guiding Catheter for Acute Coronary Syndrome: A Propensity-Matched Analysis of the Two Devices.

Authors:  Tsuyoshi Isawa; Kazunori Horie; Taku Honda; Masataka Taguri; Norio Tada
Journal:  J Interv Cardiol       Date:  2020-08-14       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.